200 related articles for article (PubMed ID: 24102070)
1. Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft.
Yadav VR; Sahoo K; Awasthi V
Br J Pharmacol; 2013 Dec; 170(7):1436-48. PubMed ID: 24102070
[TBL] [Abstract][Full Text] [Related]
2. The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress.
Sahoo K; Dozmorov MG; Anant S; Awasthi V
Invest New Drugs; 2012 Apr; 30(2):558-67. PubMed ID: 21181232
[TBL] [Abstract][Full Text] [Related]
3. CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones.
Lagisetty P; Vilekar P; Sahoo K; Anant S; Awasthi V
Bioorg Med Chem; 2010 Aug; 18(16):6109-20. PubMed ID: 20638855
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats.
Agashe H; Sahoo K; Lagisetty P; Awasthi V
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):329-37. PubMed ID: 21315563
[TBL] [Abstract][Full Text] [Related]
5. CLEFMA Activates the Extrinsic and Intrinsic Apoptotic Processes through JNK1/2 and p38 Pathways in Human Osteosarcoma Cells.
Yang JS; Lin RC; Hsieh YH; Wu HH; Li GC; Lin YC; Yang SF; Lu KH
Molecules; 2019 Sep; 24(18):. PubMed ID: 31505816
[TBL] [Abstract][Full Text] [Related]
6. Quinacrine Inhibits ICAM-1 Transcription by Blocking DNA Binding of the NF-κB Subunit p65 and Sensitizes Human Lung Adenocarcinoma A549 Cells to TNF-α and the Fas Ligand.
Harada M; Morimoto K; Kondo T; Hiramatsu R; Okina Y; Muko R; Matsuda I; Kataoka T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29207489
[TBL] [Abstract][Full Text] [Related]
7. Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer.
Rajagopalan P; Alahmari KA; Elbessoumy AA; Balasubramaniam M; Suresh R; Shariff ME; Chandramoorthy HC
Cancer Chemother Pharmacol; 2016 Feb; 77(2):393-404. PubMed ID: 26781309
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of NF-κB p65 subunit expression suppresses growth of nude mouse lung tumour cell xenografts by inhibition of Bcl-2 apoptotic pathway.
Qu Y; Qu B; Wang X; Wu R; Zhang X
Cell Biochem Funct; 2015 Jul; 33(5):320-5. PubMed ID: 26178579
[TBL] [Abstract][Full Text] [Related]
9. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
10. Remediation of hemorrhagic shock-induced intestinal barrier dysfunction by treatment with diphenyldihaloketones EF24 and CLEFMA.
Yadav VR; Hussain A; Sahoo K; Awasthi V
J Pharmacol Exp Ther; 2014 Nov; 351(2):413-22. PubMed ID: 25204337
[TBL] [Abstract][Full Text] [Related]
11. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C
Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702
[TBL] [Abstract][Full Text] [Related]
12. PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells.
Al-Hujaily EM; Mohamed AG; Al-Sharif I; Youssef KM; Manogaran PS; Al-Otaibi B; Al-Haza'a A; Al-Jammaz I; Al-Hussein K; Aboussekhra A
Breast Cancer Res Treat; 2011 Jul; 128(1):97-107. PubMed ID: 20680677
[TBL] [Abstract][Full Text] [Related]
13. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.
Zarogoulidis P; Petanidis S; Kioseoglou E; Domvri K; Anestakis D; Zarogoulidis K
Cell Signal; 2015 Aug; 27(8):1576-88. PubMed ID: 25917317
[TBL] [Abstract][Full Text] [Related]
14. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
[TBL] [Abstract][Full Text] [Related]
15. Induction of gut proteasome activity in hemorrhagic shock and its recovery by treatment with diphenyldihaloketones CLEFMA and EF24.
Rao G; Houson H; Nkepang G; Yari H; Teng C; Awasthi V
Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G318-G327. PubMed ID: 29746173
[TBL] [Abstract][Full Text] [Related]
16. Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma.
Xue W; Meylan E; Oliver TG; Feldser DM; Winslow MM; Bronson R; Jacks T
Cancer Discov; 2011 Aug; 1(3):236-47. PubMed ID: 21874163
[TBL] [Abstract][Full Text] [Related]
17. Retigeric acid B exhibits antitumor activity through suppression of nuclear factor-κB signaling in prostate cancer cells in vitro and in vivo.
Liu YQ; Hu XY; Lu T; Cheng YN; Young CY; Yuan HQ; Lou HX
PLoS One; 2012; 7(5):e38000. PubMed ID: 22666431
[TBL] [Abstract][Full Text] [Related]
18. The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo.
Yang CH; Yue J; Sims M; Pfeffer LM
PLoS One; 2013; 8(8):e71130. PubMed ID: 23940701
[TBL] [Abstract][Full Text] [Related]
19. Delphinidin reduces cell proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting EGFR/VEGFR2 signaling pathways.
Pal HC; Sharma S; Strickland LR; Agarwal J; Athar M; Elmets CA; Afaq F
PLoS One; 2013; 8(10):e77270. PubMed ID: 24124611
[TBL] [Abstract][Full Text] [Related]
20. SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells.
Langdon CG; Wiedemann N; Held MA; Mamillapalli R; Iyidogan P; Theodosakis N; Platt JT; Levy F; Vuagniaux G; Wang S; Bosenberg MW; Stern DF
Oncotarget; 2015 Nov; 6(35):37410-25. PubMed ID: 26485762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
